These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 32268133)
41. Hepatitis C virus infection of neuroepithelioma cell lines. Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002 [TBL] [Abstract][Full Text] [Related]
42. A human claudin-1-derived peptide inhibits hepatitis C virus entry. Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192 [TBL] [Abstract][Full Text] [Related]
43. Hepatitis C virus induces CD81 and claudin-1 endocytosis. Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146 [TBL] [Abstract][Full Text] [Related]
44. Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation. Abe T; Marutani Y; Deng L; Matsui C; Fukasawa M; Suzuki R; Wakita T; Matsuura Y; Shoji I J Virol; 2023 Jun; 97(6):e0065523. PubMed ID: 37272842 [TBL] [Abstract][Full Text] [Related]
45. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission. Catanese MT; Loureiro J; Jones CT; Dorner M; von Hahn T; Rice CM J Virol; 2013 Aug; 87(15):8282-93. PubMed ID: 23698298 [TBL] [Abstract][Full Text] [Related]
46. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection. Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978 [TBL] [Abstract][Full Text] [Related]
47. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7. Zhang F; Sodroski C; Cha H; Li Q; Liang TJ Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511 [TBL] [Abstract][Full Text] [Related]
48. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244 [TBL] [Abstract][Full Text] [Related]
49. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro. Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856 [TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus entry: role of host and viral factors. Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095 [TBL] [Abstract][Full Text] [Related]
51. The mechanism of HCV entry into host cells. Douam F; Lavillette D; Cosset FL Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801 [TBL] [Abstract][Full Text] [Related]
52. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177 [TBL] [Abstract][Full Text] [Related]
53. Claudin association with CD81 defines hepatitis C virus entry. Harris HJ; Davis C; Mullins JG; Hu K; Goodall M; Farquhar MJ; Mee CJ; McCaffrey K; Young S; Drummer H; Balfe P; McKeating JA J Biol Chem; 2010 Jul; 285(27):21092-102. PubMed ID: 20375010 [TBL] [Abstract][Full Text] [Related]
54. In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface. Davis C; Harris HJ; Hu K; Drummer HE; McKeating JA; Mullins JG; Balfe P Cell Microbiol; 2012 Dec; 14(12):1892-903. PubMed ID: 22897233 [TBL] [Abstract][Full Text] [Related]
55. TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway. Fletcher NF; Clark AR; Balfe P; McKeating JA J Gen Virol; 2017 Mar; 98(3):405-412. PubMed ID: 27983476 [TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus entry into host cells. Helle F; Dubuisson J Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604 [TBL] [Abstract][Full Text] [Related]
57. Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Mee CJ; Farquhar MJ; Harris HJ; Hu K; Ramma W; Ahmed A; Maurel P; Bicknell R; Balfe P; McKeating JA Gastroenterology; 2010 Mar; 138(3):1134-42. PubMed ID: 19944696 [TBL] [Abstract][Full Text] [Related]
58. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Zona L; Lupberger J; Sidahmed-Adrar N; Thumann C; Harris HJ; Barnes A; Florentin J; Tawar RG; Xiao F; Turek M; Durand SC; Duong FH; Heim MH; Cosset FL; Hirsch I; Samuel D; Brino L; Zeisel MB; Le Naour F; McKeating JA; Baumert TF Cell Host Microbe; 2013 Mar; 13(3):302-13. PubMed ID: 23498955 [TBL] [Abstract][Full Text] [Related]